glp 1 agonist anti inflammatory GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 receptor agonists as promising
Description
At 48 weeks, for example, retatrutide had reduced levels of triglycerides by up to 40.6% , and levels of a protein called apoC-III involved in glucose metabolism and inflammation by 38%
19 Nevertheless, in 2017, the FDA added an warning to Januvia's package insert that advised prescribers to weigh the risks and benefits of sitagliptin in patients at risk for HF before initiating therapy
This article is part of the PlexusDx Education Hub
It was the first drug officially approved for weight loss and paved the way for newer options
